======= PLAGL2 ======= == Gene Information == * **Official Symbol**: PLAGL2 * **Official Name**: PLAG1 like zinc finger 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5326|5326]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UPG8|Q9UPG8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PLAGL2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PLAGL2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604866|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Shows weak transcriptional activatory activity. No Pfam Domain information is available for this gene. |chylomicron assembly| |plasma lipoprotein particle assembly| |protein-lipid complex assembly| |plasma lipoprotein particle organization| |protein-lipid complex subunit organization| |positive regulation of intrinsic apoptotic signaling pathway| |regulation of plasma lipoprotein particle levels| |post-embryonic development| |regulation of intrinsic apoptotic signaling pathway| |positive regulation of apoptotic signaling pathway| |extracellular structure organization| |regulation of apoptotic signaling pathway| |sequence-specific DNA binding| |DNA-binding transcription activator activity, RNA polymerase II-specific| |transcription, DNA-templated| |nucleic acid-templated transcription| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |RNA biosynthetic process| |DNA-binding transcription factor activity| |positive regulation of cell death| |positive regulation of intracellular signal transduction| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |lipid metabolic process| |positive regulation of transcription by RNA polymerase II| |organic cyclic compound biosynthetic process| |regulation of apoptotic process| |positive regulation of transcription, DNA-templated| |protein-containing complex assembly| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of programmed cell death| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of signal transduction| |RNA metabolic process| |regulation of cell death| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |macromolecule biosynthetic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |protein-containing complex subunit organization| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp450|Artemisinin 50μM R08 exp450]]|1.7| |[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|1.73| |[[:results:exp492|iCRT14 30μM R08 exp492]]|1.79| |[[:results:exp116|AICAR 240μM R03 exp116]]|1.8| |[[:results:exp240|Pyridostatin 4μM R05 exp240]]|2.08| ^Gene^Correlation^ |[[:human genes:g:gnas|GNAS]]|0.405| Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|1/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6654 * **Expression level (log2 read counts)**: 5.77 {{:chemogenomics:nalm6 dist.png?nolink |}}